Advertisement
Demo

FDA targets two clinics marketing unapproved stem cell therapies 

May 11, 2018 , CNN Health
The US Food and Drug Administration filed two federal complaints Wednesday seeking to permanently ban two clinics from marketing stem cell products without regulatory approval and accusing them of "significant deviations" from good manufacturing practice requirements. 


Read the full story...


Trending healthcare news keywords at this moment

risk cancer patients longer sleep ceo medicaid women birth control drug hospitals research healthcare medicare researchers launches pharma lung study disease food found flu state hospital care opioid save life tied growth cvs digital doctors pain generic report americans marketing fda shutdown diabetes kids shows tip treatment change data walmart type